4//SEC Filing
Quimi Daphne 4
Accession 0001062993-25-011784
CIK 0001850119other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:24 PM ET
Size
5.3 KB
Accession
0001062993-25-011784
Insider Transaction Report
Form 4
Quimi Daphne
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-12+44,000→ 44,000 totalExercise: $0.60Exp: 2035-06-12→ Common Stock (44,000 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0001543031
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 6:24 PM ET
- Size
- 5.3 KB